Valneva SE (VALN) Change in Taxes (2021 - 2026)
Valneva SE (VALN) posted quarterly Change in Taxes of -$1138.0 for Q1 2026, up 99.76% year-on-year from -$569.67 in Q1 2025, and up 99.93% on a QoQ basis from -$1.7 million in Q3 2025.
Valneva SE (VALN) Change in Taxes (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Change in Taxes for 6 consecutive years, with -$1138.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Taxes rose 99.76% year-over-year to -$1138.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 13.36% YoY) and the FY2024 annual result came in at -$1.8 million, down 25.0% from the prior year.
- Change in Taxes climbed to -$1138.0 in Q1 2026 per VALN's latest filing, from -$1.7 million in the prior quarter.
- Over the last five years, Change in Taxes for VALN reached as high as $730.7 million in Q3 2023 and fell as low as -$731.2 million in Q2 2023.
- A 5-year average of -$356037.4 and a median of -$364714.3 in 2022 frame the typical range for Change in Taxes.
- The largest YoY upside for Change in Taxes was 243314.77% in 2023 against a maximum downside of 128413.4% in 2023.
- Year by year, Change in Taxes stood at $1.1 million in 2022, then sank by 134.81% to -$367559.2 in 2023, then jumped by 104.02% to $14793.4 in 2024, then plunged by 11600.0% to -$1.7 million in 2025, then soared by 99.93% to -$1138.0 in 2026.
- According to Business Quant data, Change in Taxes over the past three periods registered -$1138.0, -$1.7 million, and -$186624.5 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -1,137.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,137.95 |
| Mar 31, 2026 | -1,137.95 |
| Sep 30, 2025 | -1.70 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -186,624.50 |
| Jun 30, 2025 | -186,624.50 |
| Mar 31, 2025 | -467,699.21 |
| Mar 31, 2025 | -467,699.21 |
| Dec 31, 2024 | 14,793.41 |
| Dec 31, 2024 | 14,793.41 |
| Sep 30, 2024 | -514,355.33 |
| Sep 30, 2024 | -514,355.33 |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -146,796.10 |
| Mar 31, 2024 | -146,796.10 |
| Dec 31, 2023 | -367,559.23 |
| Dec 31, 2023 | -367,559.23 |
| Sep 30, 2023 | 730.67 Mn |
| Sep 30, 2023 | 730.67 Mn |